Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 1.64%102.02B | 3.71%452.93B | 9.62%323.54B | 9.18%212.09B | 3.05%100.37B | 7.56%436.71B | 3.44%295.14B | 1.11%194.26B | 10.04%97.4B | 10.82%406.03B |
| Operating income | 1.64%102.02B | 3.71%452.93B | 9.62%323.54B | 9.18%212.09B | 3.05%100.37B | 7.56%436.71B | 3.44%295.14B | 1.11%194.26B | 10.04%97.4B | 10.82%406.03B |
| Operating expenses | -2.08%-91B | -3.97%-397.71B | -10.39%-288.21B | -10.31%-188.15B | -2.50%-89.15B | -7.84%-382.53B | -2.76%-261.08B | 0.32%-170.57B | -9.25%-86.97B | -10.54%-354.73B |
| Gross profit | -1.83%11.01B | 1.91%55.22B | 3.75%35.34B | 1.04%23.94B | 7.56%11.22B | 5.61%54.18B | 9.02%34.06B | 12.79%23.69B | 17.15%10.43B | 12.75%51.31B |
| Selling expenses | 5.37%-471.78M | 0.20%-2.39B | -5.90%-1.61B | -7.86%-1.08B | -4.60%-498.54M | -25.83%-2.39B | -18.01%-1.52B | -19.50%-1B | -20.14%-476.59M | -12.63%-1.9B |
| Administrative expenses | 5.22%-3.58B | 7.48%-13.72B | 3.65%-10.06B | 2.49%-6.92B | -3.24%-3.78B | -0.55%-14.83B | -0.67%-10.44B | -4.28%-7.1B | -5.90%-3.66B | -7.51%-14.75B |
| Research and development expenses | 4.99%-2.02B | -5.48%-14.75B | -7.72%-8.89B | -10.98%-5.35B | -31.80%-2.13B | -7.72%-13.98B | -19.30%-8.26B | -15.76%-4.82B | -25.49%-1.61B | -24.31%-12.98B |
| Profit from asset sales | 708.62%46.31M | -82.42%194.99M | -51.02%127.36M | -51.51%55.32M | -139.37%-7.61M | 263.63%1.11B | 202.99%260.03M | 97.97%114.08M | -59.34%19.33M | -57.45%304.97M |
| Revaluation surplus | 23,815.79%9.01M | 125.35%100.71M | -276.52%-6M | -521.99%-6M | -26.67%-38K | -86.50%44.69M | -105.41%-1.59M | -113.69%-964K | -100.64%-30K | 363.82%331.11M |
| -Changes in the fair value of other assets | 23,815.79%9.01M | 125.35%100.71M | -276.52%-6M | -521.99%-6M | -26.67%-38K | -86.50%44.69M | -105.41%-1.59M | -113.69%-964K | -100.64%-30K | 363.82%331.11M |
| Impairment and provision | -57.81%24.33M | -15.85%-4.43B | -15.02%-1.51B | 32.00%-861.02M | 117.39%57.66M | -18.25%-3.82B | -78.70%-1.32B | -87.51%-1.27B | -3,149.43%-331.53M | -28.16%-3.23B |
| -Other impairment is provision | -57.81%24.33M | -15.85%-4.43B | -15.02%-1.51B | 32.00%-861.02M | 117.39%57.66M | -18.25%-3.82B | -78.70%-1.32B | -87.51%-1.27B | -3,149.43%-331.53M | -28.16%-3.23B |
| Special items of operating profit | -2.16%212.17M | -3.20%1.5B | -41.60%514.57M | 20.56%275.71M | -41.22%216.84M | 45.66%1.55B | 284.26%881.17M | 38.76%228.69M | 391.13%368.93M | -50.43%1.07B |
| Operating profit | 3.15%4.88B | -1.76%19.85B | 0.35%12.7B | 1.08%9.25B | 7.08%4.73B | 7.90%20.21B | 11.50%12.65B | 12.50%9.15B | 22.34%4.42B | 1.96%18.73B |
| Financing income | 40.64%462.32M | -16.58%1.35B | -0.22%985.72M | 54.19%731.73M | -9.09%328.72M | 23.81%1.62B | 25.68%987.86M | 13.49%474.57M | 119.16%361.59M | 113.85%1.31B |
| Financing cost | -4.99%-1.7B | -2.85%-6.95B | 4.51%-4.81B | 4.36%-3.28B | 2.65%-1.62B | -14.61%-6.76B | -18.05%-5.04B | -22.74%-3.43B | -33.66%-1.67B | -5.02%-5.9B |
| Special items of earning before tax | -101.79%-1.3M | -29.06%212.93M | 55.79%231.7M | 20.64%144.44M | 62.59%72.53M | 945.69%300.17M | 162.87%148.73M | 198.12%119.73M | 63.88%44.61M | 52.22%-35.49M |
| Earning before tax | -6.47%3.18B | -11.46%13.39B | 0.09%8.51B | 5.49%6.56B | 9.72%3.4B | 7.97%15.13B | 10.22%8.5B | 3.74%6.22B | 22.99%3.1B | 2.44%14.01B |
| After-tax profit from continuing operations | -11.76%2.31B | -17.49%9.76B | -0.27%6.09B | 5.65%4.8B | 11.23%2.61B | 5.05%11.82B | 6.59%6.11B | 0.26%4.55B | 27.60%2.35B | 8.00%11.26B |
| Earning after tax | -11.76%2.31B | -17.49%9.76B | -0.27%6.09B | 5.65%4.8B | 11.23%2.61B | 5.05%11.82B | 6.59%6.11B | 0.26%4.55B | 27.60%2.35B | 8.00%11.26B |
| Minority profit | -14.98%852.02M | 14.23%3.92B | 17.26%2.93B | 13.43%2B | 15.33%1B | 4.84%3.43B | -5.79%2.5B | -5.99%1.76B | 21.15%868.86M | 25.84%3.27B |
| Profit attributable to shareholders | -9.75%1.45B | -30.44%5.84B | -12.43%3.16B | 0.72%2.8B | 8.83%1.61B | 5.13%8.4B | 17.28%3.6B | 4.67%2.78B | 31.71%1.48B | 2.07%7.99B |
| Basic earnings per share | -8.11%0.034 | -31.58%0.13 | -12.50%0.07 | 0.00%0.06 | 8.82%0.037 | 5.56%0.19 | 14.29%0.08 | 0.00%0.06 | 36.00%0.034 | 0.00%0.18 |
| Diluted earnings per share | -8.11%0.034 | -31.58%0.13 | -12.50%0.07 | 0.00%0.06 | 8.82%0.037 | 5.56%0.19 | 14.29%0.08 | 0.00%0.06 | 36.00%0.034 | 0.00%0.18 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.